Trial
NCT06077903
GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Grit Biotechnology
Collaborators
—
Condition
Adult
Intervention
GT101
Why stopped
The study was terminated from a business perspective.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-05